Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 626 institutions that hold shares in the stock, with a total of 94 Million shares, which have been reported (via 13F filing form) to have a value of $12.7 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,190,708
shares
|
$1.92 Billion
0.04% of portfolio
|
Q2 2024
Added 3.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
9,996,960
shares
|
$1.35 Billion
0.02% of portfolio
|
Q3 2024
Reduced 0.59%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,148,293
shares
|
$697 Million
0.02% of portfolio
|
Q3 2024
Added 11.72%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
2,574,546
shares
|
$349 Million
0.47% of portfolio
|
Q3 2024
Added 4.31%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2024 Q3 2024 |
1,863,800
shares
|
$252 Million
3.62% of portfolio
|
Q3 2024
Reduced 1.83%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,859,232
shares
|
$252 Million
0.02% of portfolio
|
Q3 2024
Added 2.18%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
1,843,281
shares
|
$250 Million
0.3% of portfolio
|
Q3 2024
Added 50.71%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
1,764,590
shares
|
$239 Million
0.04% of portfolio
|
Q3 2024
Added 138.16%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,675,176
shares
|
$227 Million
0.02% of portfolio
|
Q3 2024
Reduced 6.88%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,497,931
shares
|
$203 Million
0.01% of portfolio
|
Q3 2024
Reduced 36.6%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,349,381
shares
|
$183 Million
0.01% of portfolio
|
Q3 2024
Reduced 12.65%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
1,347,820
shares
|
$183 Million
0.21% of portfolio
|
Q3 2022
Reduced 8.29%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
1,316,590
shares
|
$178 Million
2.82% of portfolio
|
Q3 2024
Added 90.53%
|
|
|
Dodge & Cox
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
1,287,820
shares
|
$174 Million
0.09% of portfolio
|
Q3 2024
Added 0.55%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,017,154
shares
|
$138 Million
0.02% of portfolio
|
Q3 2024
Reduced 10.19%
|
|
|
Dsm Capital Partners LLC
Palm Beach Gardens, FL |
Nov 14, 2024 Q3 2024 |
944,154
shares
|
$128 Million
1.69% of portfolio
|
Q3 2024
Reduced 5.37%
|
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
942,147
shares
|
$128 Million
0.14% of portfolio
|
Q3 2024
Reduced 5.33%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
939,000
shares
|
$127 Million
3.68% of portfolio
|
Q3 2024
Reduced 0.11%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
924,416
shares
|
$125 Million
0.1% of portfolio
|
Q2 2023
Added 27.64%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2024 Q3 2024 |
917,674
shares
|
$124 Million
3.0% of portfolio
|
Q3 2024
Added 20.9%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
894,217
shares
|
$121 Million
0.03% of portfolio
|
Q3 2024
Reduced 1.96%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
874,665
shares
|
$118 Million
0.02% of portfolio
|
Q3 2024
Reduced 30.48%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
842,197
shares
|
$114 Million
0.11% of portfolio
|
Q3 2024
Reduced 3.34%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 08, 2024 Q3 2024 |
819,968
shares
|
$111 Million
0.23% of portfolio
|
Q3 2024
Added 4.74%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
792,196
shares
|
$107 Million
0.05% of portfolio
|
Q3 2024
Reduced 18.43%
|